Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genetic Lingo01:11

Genetic Lingo

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Culturally sensitive self-management practice: a mature biopsychosocial model to improve outcomes for people living with chronic musculoskeletal conditions.

Musculoskeletal science & practice·2026
Same author

Missing voices: why ethnic minority representation in patient organizations is a priority in rheumatology.

Rheumatology (Oxford, England)·2026
Same author

Interprofessional Workshop: An Impactful Approach to Introducing Interprofessional Education to Health Professions Students.

Southern medical journal·2026
Same author

Global Burden of Sickle Cell Disease: Adequacy of Pain Control as Evidenced by Frequency of Oral Pain Medication Use, Health Outcomes, and Emotional Well-Being Across Diverse Populations.

EJHaem·2026
Same author

Expanding the RB1 variant landscape of heritable retinoblastoma: unlocking precision oncology potential in Southern Africa.

BMC cancer·2026
Same author

A Qualitative Study of the Lived Experiences of Pregnancy and Childbirth: Unheard Voices of Black Women With Sickle Cell Disease.

SAGE open nursing·2026

Related Experiment Video

Updated: May 11, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Stargardt disease: towards developing a model to predict phenotype.

Laura Heathfield1, Miguel Lacerda, Christel Nossek

  • 1UCT/MRC Human Genetics Research Unit, Division of Human Genetics, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.

European Journal of Human Genetics : EJHG
|May 23, 2013
PubMed
Summary
This summary is machine-generated.

Stargardt disease, an ABCA4-associated retinopathy, shows varying severity based on genetic mutations. This study statistically validates a genotype-phenotype model, aiding clinical trial selection and genetic counseling for this common childhood macular degeneration.

More Related Videos

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Related Experiment Videos

Last Updated: May 11, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Stargardt disease is a common inherited childhood macular degeneration caused by mutations in the ABCA4 gene.
  • The ABCA4 gene exhibits significant allelic heterogeneity, leading to diverse disease severity and age of onset.
  • A genotype-phenotype model linking ABCA4 mutations to disease severity has been proposed but statistically challenging to verify due to small patient cohorts per mutation.

Purpose of the Study:

  • To statistically validate the genotype-phenotype model for Stargardt disease using a unique cohort.
  • To assess the relative pathogenic contribution of specific ABCA4 mutations to disease onset and severity.
  • To identify potential biomarkers for clinical trial stratification and genetic counseling.

Main Methods:

  • Utilized a cohort of Caucasian Afrikaner patients in South Africa with identified founder mutations in the ABCA4 gene.
  • Developed and applied a generalized linear model to analyze genotype-phenotype correlations.
  • Assessed the impact of genetic context on the pathogenicity of individual ABCA4 mutations.

Main Results:

  • Demonstrated that the pathogenicity of an ABCA4 mutation is significantly influenced by its genetic context.
  • Provided statistical evidence supporting the genotype-phenotype model for Stargardt disease.
  • Quantified the relative contributions of seven founder mutations to disease onset.

Conclusions:

  • The study validates the genotype-phenotype model for Stargardt disease, highlighting the importance of genetic context.
  • Findings can inform the selection of patients for clinical trials targeting ABCA4-associated retinopathy.
  • Results offer valuable insights for genetic counseling of families affected by Stargardt disease.